INOVIO PHARMACEUTICALS, INC. Balance Sheet
INO|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
INOVIO PHARMACEUTICALS, INC. had $74M in total assets and $69M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44.3M | $65.8M | $14.3M | $46.3M | $71.1M | $250.7M | $22.2M | $23.7M | $57.6M | $40.5M | $33.7M | $5.6M | $17.4M | $20.0M | $30.3M |
| Accounts Receivable | - | $1.2M | - | $1.7M | $5.5M | $18.6M | $700.1K | $3.3M | $6.0M | $15.8M | $7.3M | $2.8M | $3.3M | $830.4K | $467.9K |
| Current Assets | $61.1M | $97.8M | $153.1M | $315.2M | $448.4M | $471.2M | $94.2M | $87.8M | $138.4M | $124.6M | $171.9M | $98.9M | $58.7M | $16.0M | $31.9M |
| PP&E (Net) | $2.5M | $3.7M | $5.0M | $7.7M | $17.5M | $11.3M | $12.8M | $15.9M | $18.3M | $9.0M | $7.3M | $4.6M | $2.9M | $363.0K | $295.8K |
| Goodwill | - | - | - | $10.5M | $10.5M | $10.5M | $10.5M | $10.5M | $10.5M | $10.5M | $10.1M | $10.1M | $10.1M | $10.1M | $10.1M |
| Total Assets | $74.3M | $113.2M | $171.0M | $348.5M | $495.9M | $539.8M | $144.0M | $131.1M | $187.2M | $173.7M | $213.8M | $131.8M | $88.3M | $45.1M | $61.1M |
| Current Liabilities | $43.7M | $35.3M | $42.6M | $96.9M | $65.7M | $41.7M | $32.0M | $35.3M | $35.4M | $43.8M | $31.5M | $14.0M | $29.0M | $8.4M | $11.0M |
| Shareholders' Equity | $68.5M | $117.3M | $222.4M | $399.7M | $461.1M | $461.1M | $3.4M | $86.9M | $142.4M | $123.3M | $175.7M | $111.2M | $52.5M | $34.4M | $47.3M |